Follow
International Journal of Current Microbiology and Applied Sciences (IJCMAS)
IJCMAS is now DOI (CrossRef) registered Research Journal. The DOIs are assigned to all published IJCMAS Articles.
Index Copernicus ICI Journals Master List 2018 - IJCMAS--ICV 2018: 95.39 For more details click here
National Academy of Agricultural Sciences (NAAS) : NAAS Score: *5.38 (2020) [Effective from January 1, 2020]For more details click here

Login as a Reviewer

Indexed in



National Academy of Agricultural Sciences (NAAS)
NAAS Score: *5.38 (2019)
[Effective from January 1, 2019]
For more details click here

ICV 2018: 95.39
Index Copernicus ICI Journals Master List 2017 - IJCMAS--ICV 2018: 95.39
For more details click here

See Guidelines to Authors
Current Issues

Original Research Articles

PRINT ISSN : 2319-7692
Online ISSN : 2319-7706
Issues : 12 per year
Publisher : Excellent Publishers
Email : editorijcmas@gmail.com / submit@ijcmas.com
Editor-in-chief: Dr.M.Prakash
Index Copernicus ICV 2018: 95.39
NAAS RATING 2020: 5.38

Int.J.Curr.Microbiol.App.Sci.2020.9(2): 2779-2786
DOI: https://doi.org/10.20546/ijcmas.2020.902.316


Comparison of the Efficacy of Different Therapeutic Regimen in the Management of Glaucoma in Dogs
T. C. Soundarya1*, M. A. Kshama2, Suguna Rao3 and V. Mahesh4
1Department of Veterinary Medicine, Veterinary College, KVAFSU, Bangalore-560024, India
3Department of Pathology Veterinary College, KVAFSU, Bangalore-560024, India
 4Department of Surgery Veterinary College, KVAFSU, Bangalore-560024, India
*Corresponding author
Abstract:

Eighteen dogs presented to the Veterinary College Hospital, Bangalore exhibiting clinical signs of glaucoma and IOP more than 25 mmHg were selected. These dogs were divided into 3 groups of 6 animals each and were subjected to therapeutic management of glaucoma. Group I was treated with Timolol Maleate ophthalmic solution, 1 drop, BID, Group II was treated with Dorzolamide and Timolol, 1 drop, BID and Group III was treated with Latanoprost and Timolol, 1 drop, BID . The duration of therapy was for 2 months and the dogs were monitored every once in 15 days i.e., day 0, day 15, day 30, day 45 and day 60 following initiation of therapy. It was found that Group III dogs treated with Latanoprost and Timolol combination responded better than the other two groups followed closely by Group II dogs treated with Dorzolamide and Timolol combination whereas monotherapy with Timolol was not very effective.


Keywords: Timolol, Dorzolamide and Timolol fixed combination, Latanoprost and Timolol fixed combination, glaucoma.
Download this article as Download

How to cite this article:

Soundarya. T. C, M. A. Kshama, Suguna Rao and Mahesh. V. 2020. Comparison of the Efficacy of Different Therapeutic Regimen in the Management of Glaucoma in Dogs.Int.J.Curr.Microbiol.App.Sci. 9(2): 2779-2786. doi: https://doi.org/10.20546/ijcmas.2020.902.316